iRhythm Technologies (IRTC)
(Delayed Data from NSDQ)
$71.58 USD
-2.66 (-3.58%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $71.61 +0.03 (0.04%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$71.58 USD
-2.66 (-3.58%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $71.61 +0.03 (0.04%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
Zacks News
Should Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for GSSC
IRHYTHM TECH (IRTC) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of -6.45% and 3.14%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Should Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for GSSC
Will IRHYTHM TECH (IRTC) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Most Interesting New ETFs: Sports Betting & Telemedicine
by Neena Mishra
We highlight the first sports betting ETF and a digital health ETF
iRhythm (IRTC) Looks Good: Stock Adds 9.6% in Session
by Zacks Equity Research
iRhythm (IRTC) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
IRHYTHM TECH (IRTC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
IRHYTHM TECH (IRTC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IRHYTHM TECH (IRTC) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of 40.35% and 3.49%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: IRHYTHM TECH (IRTC) Q1 Earnings Expected to Decline
by Zacks Equity Research
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate IRHYTHM TECH (IRTC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
by Zacks Equity Research
Sector ETF report for XHE
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
by Zacks Equity Research
Sector ETF report for XHE
IRHYTHM TECH (IRTC) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of -25.00% and 0.61%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
IRHYTHM TECH (IRTC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
IRHYTHM TECH (IRTC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IRHYTHM TECH (IRTC) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of -89.74% and 4.73%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
IRHYTHM TECH (IRTC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
IRHYTHM TECH (IRTC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sony (SNE) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Amid a challenging business environment, strategic partnerships and state-of-the-art product launches are likely to have benefited Sony's (SNE) fiscal second-quarter 2019 financial performance.
iRhythm Technologies Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
iRhythm Technologies has been struggling lately, but the selling pressure may be coming to an end soon.
IRHYTHM TECH (IRTC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of -2.22% and 6.89%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
IRHYTHM TECH (IRTC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IRHYTHM TECH (IRTC) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of 34.00% and 8.25%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate IRHYTHM TECH (IRTC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate IRHYTHM TECH (IRTC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IRHYTHM TECH (IRTC) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of -4.35% and 6.03%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Will IRHYTHM TECH (IRTC) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.